Catalyst Wire Dossier Catalyst Wire Dossier

Liposomal siRNA

· Arbutus Biopharma Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Liposomal siRNA, covering 2010-01-22 to 2010-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol [Phase 1]

See pricing